The University of Chicago Header Logo

Connection

Hedy Kindler to Phosphoproteins

Back to Details
This is a "connection" page, showing publications Hedy Kindler has written about Phosphoproteins.
Hedy Kindler
Connection Strength
0.019
Phosphoproteins
  1. A phase I trial to determine the safety, tolerability, and maximum tolerated dose of deforolimus in patients with advanced malignancies. Clin Cancer Res. 2009 Feb 15; 15(4):1428-34.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.